Chirfi Guindo - 04 Jun 2025 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role: Director
Signature: By: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol: BEAM
Transactions as of: 04 Jun 2025
Transactions value $: $0
Form type: 4
Filing time: 06 Jun 2025, 16:05:19 UTC
Previous filing: 01 May 2025
Next filing: 05 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Guindo Chirfi	Director	C/O BEAM THERAPEUTICS INC.,, 238 MAIN STREET, CAMBRIDGE	By: /s/ Christine Bellon, Attorney-in-fact	06 Jun 2025	0001722753

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BEAM	Stock Option (Right to Buy)	Award	$0	+33.7K		$0.00	33.7K	04 Jun 2025	Common Stock	33.7K	$17.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.